Holen Sie sich die Stockscreener-App
127.85
4.21%
5.17
Handel nachbörslich:
127.85
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BIIB?
Forum
Prognose
Aktiensplit
Biogen Inc Aktie (BIIB) Neueste Nachrichten
Will Major North Carolina Expansion Change Biogen's (BIIB) Narrative? - simplywall.st
Beacon Investment Advisory Services Inc. Sells 3,529 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division - Benzinga
Biogen, one of the largest employers in RTP, plans $2B investment in the Triangle - Axios
How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings? - The Globe and Mail
Allianz Asset Management GmbH Increases Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Los Angeles Capital Management LLC Takes $5.93 Million Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Spinal Muscular Atrophy Treatment Market Growth Accelerated - openPR.com
Is Biogen Inc. a good long term investmentExplosive wealth accumulation - jammulinksnews.com
What drives Biogen Inc. stock pricePowerful growth strategies - jammulinksnews.com
Biogen: Hold Rating Amid Stagnant Growth and Uncertain Prospects - TipRanks
Biogen to invest further $2bn in North Carolina’s Research Triangle Park - Yahoo Finance
Iovance Biotherapeutics shares rise 2.41% premarket after Biogen's $2 billion investment in North Carolina manufacturing. - AInvest
What analysts say about Biogen Inc. stockFree Predictions - jammulinksnews.com
Biogen investing $2B to expand operations in RTP - ABC11
Biogen's Alzheimer's Innovation Pipeline: Lecanemab and BIIB080 as Catalysts for Long-Term Growth - AInvest
Biogen & Partner Eisai Get EU Nod for Alzheimer's Drug Leqembi - yahoo.co
Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025 - Biogen
Biogen Inc. - Via Ritzau
Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome - Insider Monkey
Biogen Inc. Stock Analysis and ForecastExponential return rates - Autocar Professional
Biogen to invest $2 billion in RTP facility - CBS 17
Biogen Inc. Invests $2B In North Carolina Expansion - Business Facilities
Biogen Inc. Announces $2 Billion Expansion in North Carolina's Research Triangle Park Amid U.S. Manufacturing Push - Hoodline
Friedreich's Ataxia Market Is Expanding Due To Advancing - openPR.com
Biogen (BIIB) Stock Trades Down, Here Is Why - Yahoo Finance
Biogen Bets Big On $2 Billion Expansion To Boost US Drug ManufacturingBiogen (NASDAQ:BIIB) - Benzinga
Biogen invests $2B in U.S. manufacturing — but not in Massachusetts - The Business Journals
Biogen to invest $2 billion in Research Triangle Park facilities - CBS 17
Biogen to invest $2 billion in RTP, open new factory in 2025 - WRAL.com
Biogen’s Pediatric RRMS Study Completion: Market Implications and Insights - TipRanks
Biogen (NASDAQ:BIIB) Coverage Initiated by Analysts at Truist Financial - MarketBeat
Biogen to invest further $2 billion in North Carolina facilities - The Pharma Letter
Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm - Reuters
Drugmaker Biogen to invest $2 billion more in North Carolina - 104.1 WIKY
Truist downgrades Biogen, citing growth challenges, limited pipeline upside - TradingView
Biogen Announces Additional Investment In North Carolina's RTP - Nasdaq
Biogen (BIIB) Increases Investment in North Carolina Manufacturi - GuruFocus
Biogen to invest $2 billion more in North Carolina By Reuters - Investing.com
Biogen Announces $2 Billion Manufacturing Investment in North Carolina's Research Triangle Park in Conjunction with its 30th Anniversary | BIIB Stock News - GuruFocus
Biogen to invest $2 billion in North Carolina manufacturing expansion By Investing.com - Investing.com India
Biogen Announces $2 Billion Investment to Expand Manufacturing in North Carolina's Research Triangle Park - Quiver Quantitative
Biogen to invest $2 billion more in North Carolina - Reuters
Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary - The Manila Times
Biogen Commits $2B for Manufacturing Expansion in Research Triangle Park | BIIB Stock News - Stock Titan
Twin Capital Management Inc. Has $1.58 Million Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Central Nervous System (CNS) Biomarkers Market is expected - openPR.com
Q3 Earnings Estimate for Biogen Issued By William Blair - MarketBeat
Edgestream Partners L.P. Sells 3,285 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Brokerages Set Biogen Inc. (NASDAQ:BIIB) Price Target at $188.48 - MarketBeat
New York State Common Retirement Fund Purchases 20,130 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Cwm LLC - MarketBeat
Alps Advisors Inc. Purchases New Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Wedbush Issues Pessimistic Forecast for Biogen Earnings - MarketBeat
Cerity Partners LLC Has $5.52 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Rachid Izzar Sells 2,223 Shares of Biogen Inc. (NASDAQ:BIIB) Stock - MarketBeat
Insider Selling Spree: Fastly, Biogen, Kroger, Bloom, and Pure Investors Unload Shares - AInvest
1.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):